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a b s t r a c t
The use of digital PCR for quantiﬁcation of nucleic acids is rapidly growing. A major drawback remains the
lack of ﬂexible data analysis tools. Published analysis approaches are either tailored to speciﬁc problem
settings or fail to take into account sources of variability. We propose the generalized linear mixed models
framework as a ﬂexible tool for analyzing a wide range of experiments. We also introduce a method
for estimating reference gene stability to improve accuracy and precision of copy number and relative
expression estimates. We demonstrate the usefulness of the methodology on a complex experimental
setup.
© 2016 The Author(s). Published by Elsevier GmbH. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

1. Introduction
The number of publications on digital PCR (dPCR) have markedly
increased during the last decade, with a rapid growth of publications in the ﬁeld of biomedical sciences in recent years. This
adoption has in part been possible due to an increase of commercially available, user-friendly instruments [1,2] and is further
stimulated by positive reports on dPCR demonstrating the advantages over quantitative PCR (qPCR) [3], particularly for applications
such as low-level quantiﬁcation [4,5], absolute quantiﬁcation [4,5]
and copy number variation (CNV) determination [6].
Despite the advantages and increasing popularity of dPCR and
as a consequence of the technique still being in its infancy, one
major drawback of dPCR remains the lack of dedicated data analysis
tools taking full advantage of the speciﬁc digital nature of the data.
Most published papers rely on data-analysis software provided by
hardware manufacturers. These software suites are typically blackbox tools providing the user with a limited amount of information

∗ Corresponding author.
E-mail address: matthijs.vynck@ugent.be (M. Vynck).

on the algorithms. They furthermore do not allow the user to
analyze more complicated experimental setups such as the correct
use of technical replicates or the use of multiple reference loci for
determining CNVs, even though such approaches may be advisable
[7–9].
Although several papers have been published that propose data
analysis methods, these methods have been developed to analyze
very speciﬁc experimental setups. For example, Whale et al. [6] and
Dube et al. [10] developed ad hoc methods for calculating CNVs, but
these methods can only be used to calculate CNVs using a single
reference locus and do not take into account interreplicate variability. Extending these methods to cope with other experimental
setups would require signiﬁcant work, tailored to each of these speciﬁc designs. A major difﬁculty is the correct estimation of standard
errors and conﬁdence intervals.
In this paper, we detail how the established generalized linear
mixed model (GLMM) framework [11] can be used to analyze dPCR
data from a wide range of experimental setups, ranging from simple
experiments such as absolute quantiﬁcation to complicated studies
such as CNV estimation with multiple reference loci normalization
and handling of variable numbers of technical replicates, while correctly accounting for various sources of variability. The basis of this

http://dx.doi.org/10.1016/j.bdq.2016.06.001
2214-7535/© 2016 The Author(s). Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-ncnd/4.0/).
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GLMM framework has recently also been described by Dorazio and
Hunter [12]. We argue that known sources of variability should be
accounted for and that the approach of pooling counts of technical
replicates used for analysis by Dorazio and Hunter [12] (among others, e.g. Yu et al. [13]) may lead to incorrect estimation of standard
errors and conﬁdence intervals.
Further, a novel approach for selecting stable reference loci for
CNV studies from a pool of candidate reference loci is developed
and successfully applied. An approach for reference gene selection
in relative expression experiments is also suggested.
To demonstrate the ﬂexibility of the approach, our methodology
is used to analyze a dataset consisting of droplet digital PCR (ddPCR)
data for 14 individuals who have been screened for chromosomal
abnormalities using 14 genes on 6 chromosomes. The performance
in terms of accuracy and precision is evaluated for calculating CNVs
using both a single reference locus and multiple reference loci.
2. Materials and methods
2.1. Absolute quantiﬁcation
dPCR splits a sample mixture into partitions. Each of these partitions is subsequently called as containing target nucleic acid, or
having no target nucleic acid. A positive signal thus indicates that
one or more target copies may be present. As a consequence of the
random partitioning of copies, the number of copies in a partition is
assumed to follow a Poisson distribution with parameter  which
has the interpretation of the average number of copies per partition. If Yj∗ denotes the unobserved number of copies in partition j
(j = 1, . . ., J, with J the number of partitions), then we can write the
observed digital outcome as the binary variable Yj :



Yj =

min(Yj∗ , 1)

=

0

(1)

1 otherwise.

0
exp(−) = exp(−)
0!

(2)

 = − log P{Yj∗ = 0} = − log P{Yj = 0}

(3)

The ﬁnal equality in Eq. (3) follows from the construction of the
binary outcomes (Eq. (2)). Since a probability of a binary event can
be estimated from simple counts, an estimate of  is given by
ˆ = − log


 number of negative partitions 
total number of partitions

.

(4)

ˆ can also be obtained using a Generalized Linear Model (GLM).

The GLM for the unobserved counts Yj∗ is speciﬁed by a Poisson

distribution with mean  related to a parameter ˇ0 through a loglink function,
log  = ˇ0 .

(5)

Using Eq. (3), the observed binary outcomes Yj can be described by
a binomial distribution with probabilities
P{Yj = 0}

= P{Yj∗ = 0} = exp(−)
= exp(− exp(ˇ0 ))

P{Yj = 1}

= P{Yj∗ > 0} = 1 − exp(−)
= 1 − exp(− exp(ˇ0 )).

log(− log(P{Yj = 0})) = ˇ0 ,

ˆ 0 ).
ˆ = exp(ˇ


(8)

Using Eq. (4) or Eq. (8) will result in the same estimate for .
Assuming a constant volume of the partitions, say Vpartition , the
concentration can be estimated from the average number of copies
per partition (Eq. (9)):
ĉ =

ˆ

.
Vpartition

(9)

To obtain a reliable estimate of the concentration, an experiment
is typically replicated. We now deﬁne Yij∗ as the number of copies
in partition j of replicate i (j = 1, . . ., Ji , with Ji the number of partitions in replicate i, i = 1, . . ., I, with I the number of replicates). As
before, the counts are not observable, but upon applying equation
(1), binary outcomes Yij can be calculated. To take the replicate variability into account, we introduce a random effect for the replicate
in the Poisson model. Within a replicate, the counts are still Poisson distributed. The statistical model is formulated hierarchically.
In particular, within a replicate:
Yij∗ | Ri ∼Poisson(i )

(10)

where
(11)

with Ri the effect of replicate i on the Poisson mean. These replicate
effects Ri are described by a normal distribution,
Ri ∼N(0,  2 ).

(12)

This model implies that the random effect terms are exchangeable, which is warranted if replicates are considered as a random
sample from a larger population of potential replicates (see
Supplementary Material 4, Section 4).
The model results again in a binomial regression model with a
complementary log-log link for the observed digital outcomes. In
particular, within a replicate
log(− log(P{Yij = 0 | Ri })) = ˇ0 + Ri ,

(13)

with ˇ0 and Ri as before. The model is a special case of a GLMM [11].
Statistical software is available for estimating the model parameters (e.g. R [14], an environment often used for analysis of PCR
experiments [15]), including random effect variances [16].
The objective is to estimate the mean number of copies, averaged over all replicates, i.e. E{Yij∗ } is the quantity of interest for
absolute quantiﬁcation. Statistical theory (Supplementary Material
4, Section 1) gives
E{Yij∗ } = exp(ˇ0 + 0.5 2 ).

(14)

ˆ 0 ), the estimate of the variance
From the estimate of ˇ0 (say ˇ
 2 of the random effect (say ˆ 2 ) and from Eq. (9) a concentration
estimate can subsequently be calculated as
ĉ =

(6)

(7)

where ˇ0 is the same as in Eq. (5). Since the digital outcomes Yj are
ˆ 0 denotes
observed, GLM software can be used for estimating ˇ0 . If ˇ
the estimate, an estimate of  is then given by

log i = ˇ0 + Ri ,

if Yj∗ = 0

Having observed the digital outcomes, the  parameter of the
Poisson distribution can be estimated from the probability of zero
copies, relying on the probability mass function of the Poisson distribution (Eqs. (2) and (3)):
P{Yj∗ = 0} =

Eqs. (6) state a GLM for a binomial distribution with a complementary log-log link. The more conventional model formulation
is:

ˆ 0 + 0.5ˆ 2 )
exp(ˇ
.
Vpartition

(15)

The statistical software also gives the estimated standard
ˆ 0 which can be used for the calculaerrors of the estimates ˇ
tion of an approximate conﬁdence interval of the concentration
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(Supplementary Material 4, Section 3). Example analyses are given
in Sections 2.1 and 3.2 of Supplementary Material 1.

by
CNVi =

2.2. Copy number variation

2.2.1. Single reference designs
The same notation (Yij and Yij∗ ) as before is used, but the partition
index j may now refer to a measurement which can be from a target
or a reference. The distinction between target and reference is made
by a dummy regressor Xij which is deﬁned as zero when partition (i,
j) comes from the target and one when it comes from the reference.
For the designs A and B (Fig. 1), the model for the unobservable
number of copies is written as
| Ri ∼Poisson(ij )

(16)

where
log ij = ˇ0 + Xij ˇ1 + Ri

(17)

and
2

Ri ∼N(0,  ).

(18)

Thus within replicate i, the mean number of target copies per partition again equals exp(ˇ0 + 0 × ˇ1 + Ri ), and the mean number of
reference copies per partition equals exp(ˇ1 + 1 × ˇ1 + Ri ).
Let ctarget,i and cref,i denote the concentrations of target and reference in replicate i, respectively, and Nb the ploidy of the organism.
For design A (Fig. 1), the CNV based on replicate i for the target and
replicate i for the reference, is given by
CNVi,i =

ctarget,i
cref,i

Nb =

exp(ˇ0 + 0 × ˇ1 + Ri )/Vpartition
exp(ˇ1 + 1 × ˇ1 + Ri )/Vpartition

= exp(−ˇ1 + Ri − Ri )Nb .

Nb
(19)

The overall CNV is then given be the average of CNVi,i over
all replicates (see Supplementary Material 4, Section 2 for details),
resulting in
CNV = E{CNVi,i } = exp(−ˇ1 +  2 )Nb .

cref,i

Nb =

exp(ˇ0 + 0 × ˇ1 + Ri )/Vpartition
exp(ˇ1 + 1 × ˇ1 + Ri )/Vpartition

Nb

(21)

with ˇ0 , ˇ1 and Ri as in model (17).
For design B (Fig. 1), the CNV based on replicate i, which now
contains droplets with both target and reference (duplex), is given

(22)

Note that the random effect cancels out and that the CNV does not
ˆ 1 )Nb ,
depend on i. Hence, an overall CNV estimate is given by exp(−ˇ
with the estimates again calculated from the GLMM with a complementary log-log link. The random effect can however not be
omitted altogether, as it inﬂuences the variance on the ﬁxed effect
parameters, and thus the inclusion of the random effect is essential
for a correct error propagation.
2.2.2. Multiple reference designs
The model can be further extended to contain multiple reference
loci. The number of copies and the deduced binary outcome for
∗ and Y , respectively, in which
partition (i, j) are denoted by Yijk
ijk
the index k refers to the reference k = 1, . . ., K, with K the number
of reference loci and with k = 0 referring to the target. Consider the
dummy Xijk , which is deﬁned as one when the signal belongs to
the kth reference and zero when the signal comes from the target.
Reference-to-reference differences are allowed by making use of
nested random effects.
For designs C and D, for a given replicate i and for a given target
∗ has
or reference k, the Poisson model for the unobserved counts Yijk
log-mean
∗
log E{Yijk
| Sk , Ri(k) } = log ijk = ˇ0 + ˇ1 Xijk + Sk Xijk + Ri(k)

(23)

with Sk the effect of reference k on the log-mean, and Ri(k) the effect
of the ith replicate of the experiment with the PCR mix containing reference k (or k = 0 for target in design C). The variability of
these two random effects are described by independent normal
distributions:
Sk ∼N(0, 12 ) and Ri(k) ∼N(0, 22 ).

(24)

Hence, Sk is a random effect for the between reference locus
variation and Ri(k) is a random effect for the interreplicate variation
nested within a given target or reference. Note that the model formulation assumes that the random effects are exchangeable (see
Supplementary Material 4, Section 4 for more information).
The same model applies to design E, except that the index k in
Ri(k) should be replaced by an index k* which is an indicator of the
unique PCR mix (each row in panel E of Fig. 1 represents a unique
PCR mix). The model for design F is also similar, except that the
replicate effect Ri(k) does not depend on reference k, because in this
multiplex experiment all references are potentially included in all
partitions, i.e. in each replicate all references are included in the
PCR mix. Hence, the nested random effect Ri(k) in model (23) has to
be replaced by Ri .
As before, the model parameters can be estimated from the corresponding GLMM for the binary outcome:
log(− log(P{Yijk = 0 | Sk , Ri(k) })) = ˇ0 + ˇ1 Xijk + Sk + Ri(k) .

(25)

For design C the CNV is ﬁrst given for target versus a single
reference k, based on replicates i and i :

(20)

As before, the model parameters may be estimated by reformulating the model for the digital outcomes Yij . In particular, a GLMM
with a complementary log-log link is obtained:
log(− log(P{Yij = 0 | Ri })) = ˇ0 + Xij ˇ1 + Ri ,

ctarget,i

= exp(−ˇ1 )Nb .

For the estimation of CNV, data on both a target and at least
one reference must be available. Several experimental designs are
appropriate for obtaining target and reference measurements. Fig. 1
shows six examples, ranging from single reference settings with
single channel experiments (panel A) or duplex experiments (panel
B) to multiple reference studies with single channel (panel C) or
duplex (panel D, E) or multiplex (panel F) experiments. In this section, a GLMM methodology is outlined that is applicable to all of
these designs, also in the presence of replicates.
The general guideline for obtaining valid statistical estimation,
error propagation and hypothesis testing, is that the data analysis
method should account for dependencies and sources of variability
implied by the experimental setup. For example, as in Section 2.1,
random replicate effects should be included in the model to take
care of the dependence between droplets within the same replicate.

Yij∗

3

CNVi,i ;k =

exp(ˇ0 + Ri(0) )
exp(ˇ1 + ˇ1 + Sk + Ri (k) )

Nb

= exp(−ˇ1 − Sk + Ri(0) − Ri (k) )Nb .

(26)

The overall CNV is obtained by averaging over all replicates and
all references (see Supplementary Material 4, Section 2 for details):



CNV = E{CNVi,i ;k } = exp −ˇ1 +



1 2
 + 22 Nb .
2 1

(27)
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Fig. 1. Experimental designs for calculating copy numbers using digital PCR. (A) Singleplex experiments with a single reference gene. (B) Duplex experiments with a single
reference gene. (C) Singleplex experiments with multiple reference genes. (D) Duplex experiments with multiple reference genes and repeated analysis of the target gene.
(E) Efﬁcient duplex experiments with multiple reference genes. (F) Multiplex experiments with multiple reference genes. For each design, a single droplet is shown for each
replicate. The circles represent partitions and they show whether a target or a reference is included in either singleplex, duplex or multiplex. The replicates are indicated
with the letter R, the total number of replicates is given by I. Setup-speciﬁc subscripts (prime, asterix) as used in the model speciﬁcations of Section 2.

For design D, which allows for CNV calculation w.r.t. a single
reference k within a replicate i (duplex), we ﬁrst give



CNVik =

exp ˇ0 + Ri(k)





exp ˇ1 + ˇ1 + Sk + Ri(k)

 Nb = exp(−ˇ1 − Sk )Nb .

CNVik =
(28)



1
CNV = E{CNVik } = exp −ˇ1 + 12 Nb .
2

(29)

For design E, the CNV w.r.t. a single reference measured in
duplex with the target is given by equation (28). CNVs for the other
k − 1 references measured in duplex with respect to one another
are given by equation (26). An overall CNV is obtained as



CNV = exp −ˇ1 +



1 2
 Nb
2 1

exp(ˇ0 + Ri )
Nb = exp(−ˇ1 − Sk )Nb .
exp(ˇ1 + ˇ1 + Sk + Ri )

(31)

Also here the replicate effect is eliminated. After averaging over
references, the overall CNV becomes

Note that the replicate effect has been eliminated (due to combining target and reference k in the duplex). After averaging over
references, the overall CNV becomes



For design F (multiplex) we also start with the CNV calculation
w.r.t. a single reference k within a replicate i:

(1 + exp(22 )(k
k

− 1))



CNV = E{CNVik } = exp −ˇ1 +

(30)

(32)

Detailed derivations are available in Supplementary Material
4. Example analyses in R are given in Sections 2.2 and 3.3 of
Supplementary Material 1.
2.3. Reference gene stability
Reference locus stability for CNV estimation is calculated for
each reference locus k (k = 1, . . ., K) as


.



1 2
 Nb .
2 1

Stabilityk =

l ∈ Sk





ˆ 1kl )
ˆ 2 + Var(ˇ
ˇ
1kl
K −1

(33)
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where Sk is the set {1, . . ., K} \ k. If only data from one sample are
ˆ 1kl are parameter estimates that result from ﬁtting
available, the ˇ
the model
log ij = ˇ0kl + ˇ1kl Xij + Ri

(34)

with Ri ∼ N(0,  2 ) and Xij

deﬁned as zero when partition (i, j) comes
from reference k and one when it comes from reference l. For ﬁtting model (34) only the data from references k and l are used. An
example analysis is given in Section 2.3 of Supplementary Material
1.
For across-sample stability in the CNV case, the model needs to
account for variability between samples: similarly to the introduction of the between-reference gene random effect in Section 2.2,
we introduce a between-sample random effect Ss that accounts for
the sample-speciﬁc effects. Consequently, model (34) is replaced
by
log ij = ˇ0kl + ˇ1kl Xij + Ri(s) + Ss
Ri(s) ∼N(0, 12 ),

(35)

Ss ∼N(0, 22 )

with
and Xij deﬁned as before. Again
only the data from references k and l are used.
The rationale for this stability measure is based on two arguments. First, when given a set of candidate reference genes in a
CNV setup, we expect these reference genes to have similar copy
numbers. If two candidate reference genes, say k and l, are in agreement (e.g. they both show a close to diploid copy number in e.g. a
ˆ 1kl is expected to be close to zero,
human sample), the estimate ˇ
or, equivalently, the ratio of their estimated concentrations will be
close 
to one (Eqs. (20) and (22)). Thus, a reference k that gives a
ˆ 2 is said to be a biased reference.
ˇ
large
l∈S
1kl
k

Second, a good reference gene will be stable across replicates
ˆ 1kl ) estimate: if
or samples, warranting the inclusion of the Var(ˇ
copy numbers across replicates or samples are highly variable, this
ˆ 1kl (i.e. a large Var(ˇ
ˆ 1kl )).
will be reﬂected in a large variability of ˇ
Thus, references that are highly variable are less ideal and will be
penalized. A detailed discussion is presented in Section 3.2.
To allow for different quantities of reference genes in a relative
expression scenario (see detailed discussion in Section 3.2), model
(35) is used, but the relative expression gene stability is simpliﬁed
to





Stabilityk =

l ∈ Sk

ˆ 1kl
Var ˇ



K −1

(36)

i.e. only taking variability into account.
2.4. Generic formulation
Generally, the model can be written as a combination of ﬁxed
effect parameters – such as those of target and reference genes but
also confounders or baseline variables, for example, age and gender
– and random effect parameters such as interreplicate variation,
interreference gene variation but also to account for e.g. variation
between multiple laboratories. The general model can be written
as
log . = ˇ0 + ˇ1 X1. + · · · + ˇp Xp. + Z1. + · · · + Zq.

(37)

for p ﬁxed effects and q random effects, where the subscripts which
are here denoted by ·, refer to the variables used for constructing
the X and Z variables. The model can further be extended to allow
for interactions, and random effects may be nested if implied by
the study design.
One example of such an extension could be relative concentration estimation with multiple patients and with an effect of gender
on the target concentration:
log ij = ˇ0 + X1ij ˇ1 + X2ij X3ij ˇ2 + Z1i

(38)

5

for partition j obtained from patient i, X1ij is one if partition j of
patient i is from the reference gene and zero if it is from the target
gene, X2ij is zero if patient i is male and one if the patient is female
and X3ij is zero for reference genes and one for target genes. The
CNV for a male remains as in Eq. (22), but for females it becomes:
ˆ
ˆ
 = ĉtarget N = exp(ˇ0 + ˇ2 ) N = exp(ˇ
ˆ2 − ˇ
ˆ 1 )Nb .
CNV
b
b
ˆ0 + ˇ
ˆ 1)
ĉref
exp(ˇ

(39)

Similarly, random effects can be added to account for e.g. stratiﬁcation in multicenter trials. Absolute concentration estimation
with an age effect, a patient effect and a center effect, could be
modelled as:
log ijc = ˇ0 + X1ijc ˇ1 + Z1c + Z2i(c)

(40)

where for center c, patient i and partition j, ˇ1 is the age effect, Z1c is
the random center effect (with variance 12 ) and Z2i(c) is the random
patient effect (nested within the center effect, with variance  2 2 ).
Using results similar as in Eq. (14), the mean concentration for a
patient of age age can then be estimated as
ˆ partition =
ĉ = /V

ˆ 1 + 0.5ˆ 2 + 0.5ˆ 2 )
ˆ 0 + age × ˇ
exp(ˇ
1
2
Vpartition

.

(41)

For all models, the corresponding binary GLMM with complementary log-log link function is available in statistical software (e.g.
R [14,16]).
2.5. Case study data
14 genes of interest (13 target loci located on chromosomes 13,
18, 21, X and Y along with a single reference locus for normalization,
RPP30, located on chromosome arm 10q for normalization) from 10
samples with chromosomal abnormalities and 4 control samples
were analyzed. DNA was extracted from blood samples using the
QIAamp DNA Blood Mini Kit (Qiagen) according to the manufacturer’s instructions, after which DNA concentration was measured
using UV spectrophotometry (Nanodrop). All patient samples and
healthy control samples were diluted to 5 ng/l using nucleasefree water and 10× carrier solution (Roche’s tRNA from brewer’s
yeast, cat-no 10109517001, 50 ng/l) making the ﬁnal tRNA carrier concentration 5 ng/l. The no template control (NTC) sample
also contained 5 ng/l carrier. Two l of the diluted DNA sample
was added into the ﬁnal ddPCR reaction resulting in a 10 ng sample input. Primers and probes were diluted to a work solution of
5 M and 2 M, respectively, using 1× IDTE buffer, pH8 (cat-no
11-05-01-09). One ddPCR master mix was created per assay/probe
pair (FAM/HEX or VIC) to perform 3 reactions per sample, control
and NTC. One 20 l reaction consisted out of following reagents:
10 l 2× ddPCR Supermix for probes (Bio-Rad; cat-no 1863010),
250 nM of each forward and reverse primer (ﬁnal concentration),
100 nM of each probe (ﬁnal concentration), and 2 l of sample
DNA (5 ng/l, 10 ng ﬁnal input) or nuclease-free water as NTC. The
20 l ddPCR reaction mix was added to the droplet generator cartridge together with 70 l droplet generation oil (Bio-Rad, cat-no
1863005). Droplets were generated using a Bio-Rad QX100 droplet
generator, followed by gentle transfer to a Twin.tec semi-skirted
96-well PCR plate. Using a Bio-Rad T100 thermal cycler, the following temperature cycling program was used for target ampliﬁcation:
10 min 95 ◦ C activation, 40 cycles of 30 s 95 ◦ C and 1 min 59 ◦ C,
followed by 10 min 98 ◦ C. After PCR ampliﬁcation, the plate was
analyzed using a QX100 droplet reader using Quantasoft software.
Data was exported as a CSV ﬁle for further processing.
Primers and hydrolysis probes were designed using an in house
developed primerXL assay design engine (Lefever et al., in preparation; http://www.primerxl.org), avoiding SNPs under the primer
and probe annealing sites, avoiding secondary structures, and
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assessing primer speciﬁcity using genome wide Bowtie [17] primer
alignment, avoiding primers that have fewer than three mismatches to a possible off-target homologous sequence. All primers
and probes were ordered at Integrated DNA Technolgies, except
for the RPP30 probe which was ordered from Life Technologies.
Sequences are available in Supplementary Table 1.
To allow comparison with digital PCR results, samples were also
analyzed using arrayCGH, karyotyping and/or FISH in an ISO 15189
accredited lab at the Center for Medical Genetics, Ghent University
Hospital as described before [18–20].
2.6. Data analysis
To assess the inﬂuence of ignoring interreplicate variation in the
case of absolute quantiﬁcation, GLM and GLMM models were ﬁtted.
The GLM model (Eq. (5)) did not account for interreplicate variation, and thus the analysis was based on pooling the negative and
positive droplet counts. The GLMM (Eq. (11)), on the other hand,
was ﬁtted using a random effect to account for the interreplicate
variation. Estimates of both approaches and their variances were
compared.
Using the proposed framework, the copy numbers for each of
the target loci was calculated by using the RPP30 locus as a reference (model equation (20) or (22), Fig. 1, panel A or B, depending
on the target locus). Copy numbers were also calculated, again by
constructing GLMM models, by using all loci located on autosomal
chromosomes with close to normal diploid copy number as references (model equation (30), Fig. 1, panel E), except for sample
10 where no loci with normal diploid copy number were distinguishable. Model evaluation was done by calculating the mean
absolute deviation from the closest integer copy number over all
non-reference locus copy numbers in a given sample.
To assess accuracy and precision with an increasing number
of reference loci, target locus copy numbers were estimated by
sequentially adding reference loci. To limit computational burden
this was done for both a best case scenario, where the most stable
reference loci were added ﬁrst, and a worst case scenario, where
the least stable reference loci were added ﬁrst. After each step of
adding a reference locus, accuracy was assessed by calculating the
mean absolute deviation from integer copy numbers of the targets.
Precision was assessed by calculating the mean width of all target
95% conﬁdence intervals.
For each of the patient samples in the case study, reference locus
stability was determined using the stability measure described in
Section 2.3 (model (34)). Retaining the most stable reference loci
only, ﬁnal copy numbers were determined for each of the target
loci (Eq. (30), setup as in Fig. 1, panel E).
3. Results and discussion
There is a clear need for more ﬂexible data analysis tools for dPCR
experiments. The GLMM framework is ideally suited to accommodate a wide range of dPCR experimental setups. As outlined
in Section 2, the framework can be used for absolute quantiﬁcation, CNV calculation and gene expression analysis (with or without
replicates), but it can also accommodate other applications such
as mutation quantiﬁcation both in singleplex, duplex or higher
multiplexing mode, making it compatible with all existing dPCR
instruments. As further demonstrated in Section 2, the framework
also allows adjusting for e.g. clinical baseline covariates such as age
or gender, including treatments effects, or analyzing multicenter
trials.
The type of the data we have collected, allows us to assess differences between classical approaches and those described in this
paper. The initial setup of the experiment was to study 13 target loci

Fig. 2. Variability across replicates and reference loci. Parameterestimates of absolute quantities of the 14 candidate reference loci in 13 samples. Loci displayed are
those with close to diploid copy number. Loci with a single or three copies are not
displayed. For each reference locus and each sample, technical replicates are shown.
The graphs demonstrate the presence of substantial variability between technical
replicates, between samples and between reference loci.
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along with a single reference locus for normalization. Because the
patients in this study suffer from only one type of chromosomal
abnormality, loci located on the non-affected chromosomes will
still retain their normal copy number status. In principle, this allows
the use of loci located on unaffected chromosomes as reference
loci, in addition to the RPP30 reference locus. Studying chromosomal loss or gain furthermore has the advantage that under ideal
reaction conditions and assuming no mosaicism, copy numbers are
expected to be integers. This is in contrast to e.g. expression levels
that may take any (non-integer) value. This property of the study
allows to measure accuracy as a deviance from an integer copy
number.
3.1. Variance modelling
The need for modelling the different sources of variability
becomes apparent from the estimates as obtained from the GLM
models. As evidenced by Fig. 2 there is often substantial variability between technical replicates as well as between reference loci.
Not accounting for these sources of variability may lead to overly
optimistic uncertainty estimates. This is observed when comparing the uncertainty estimates of a naive pooling strategy (ignoring
interreplicate variability) with those of a GLMM model accounting
for interreplicate variability in an absolute quantiﬁcation scenario.
Fig. 3 shows a histogram of the ratio of the variance of the absolute quantiﬁcation obtained with the pooling strategy relative to
the variance calculated from the GLMM method. Even though the
variability estimates of both methods are often close in our experimental data (in a majority of samples the fold difference was
approximately one), the variability was underestimated up to a
factor 10 when using a naive pooling strategy (Fig. 3). It is thus recommended to always incorporate the interreplicate variability to
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avoid overoptimistic variance estimates. This has also been demonstrated by Jacobs et al. [21] through simulation: pooling replicate
data results in faulty conﬁdence intervals, while accounting for
interreplicate variation results in correct variance estimates and,
consequently, correct conﬁdence intervals.
The same holds true for accounting for variability between reference loci: there is often a discrepancy between different candidate
reference loci (Fig. 2) and ignoring this may result in an underestimation of the uncertainty on relative quantity or CNV estimates.
Dorazio and Hunter [12] argue that accounting for additional
sources of variability should only be considered if concentrations
are expected or can be shown to be different. One can argue that
due to the imperfectness of e.g. sample processing in a typical
experiment (e.g. using replicates) such sources of variation will
always be present and should always be considered [21]. Dorazio
and Hunter [12] furthermore propose the use of deviance statistics
to assess model goodness of ﬁt. They argue that their model is not
worse than the saturated model based on this deviance statistic, but
they do not make a comparison with models accounting for additional sources of variability such as interreplicate variability. Even
if such a comparison would demonstrate that a model not accounting for interreplicate variability is not signiﬁcantly worse than one
accounting for interreplicate variability, this may be a weak conclusion as goodness of ﬁt tests may suffer from a lack of power [22].
For example, using our data we found that a lack of ﬁt was detected
only when the uncertainty using the GLMM method was approximately at least three times that of the uncertainty estimated using
the GLM method (results not shown). When unsure about the presence or power of detecting additional sources of variation, it is thus
better to be cautious and to allow for the possibility of these additional sources of variability, rather than to take the risk to obtain
too optimistic results.

Fig. 3. Importance of modelling variability. Histogram of the ratio of variances of the parameter estimates of the naive pooling method relative to the GLMM. A ratio smaller
than one indicates that the pooling method is too optimistic: the variance estimate of the pooling method is smaller than the variance estimate accounting for interreplicate
variation. Ignoring this variation results in a variance estimate that is too small and consequently conﬁdence intervals that are too narrow. It is recommended to always
account for the possibility of variation between replicates to get an accurate variance estimate.
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Fig. 4. Effect of normalization strategy Effect of normalization strategy on the mean absolute deviation from integer copy numbers for nine samples with chromosomal
abnormalities. A low mean absolute deviation indicates that the obtained estimates are close to the expected copy numbers. Using multiple stable reference loci can result
in a drastic increase in accuracy if the single reference locus was biased. If it is not beneﬁcial, the difference with the single reference locus is small.

3.2. Multiple reference loci
It is recommended to use multiple reference loci, for relying
on a single reference locus for calculating a CNV may result in
reduced accuracy [7,23]. Especially in the case of e.g. erroneous
ampliﬁcation (e.g. due to inhibition) or copy number alteration of
the candidate reference locus, estimated copy numbers may be far
from accurate. This is clearly observed in the results from the case
study, particularly in sample 15: when relying solely on the locus
located on the RPP30 gene, which is a popular reference gene in
CNV studies [24], an underestimate of copy numbers of target loci
is obtained. This has also been observed in other studies. For example, Versluis et al. [8] observed a gain of the TERT reference gene in
two samples, resulting in erroneous results. They argue that relying
on 3 to 4 reference loci would circumvent this problem.
These problems can indeed be remediated by relying on multiple reference loci, in which case e.g. erroneous ampliﬁcation of
one of the reference loci will only partially inﬂuence the estimated
copy number. This is illustrated in Fig. 4 where relying on the
predetermined reference locus on the RPP30 gene often results in
much larger mean absolute deviations from integer copy numbers
when compared to relying on multiple reference loci. In those samples where the single locus normalization performs much worse,
the RPP30 locus is unsuitable for normalization (Supplementary
Material 2).
The accuracy of the estimate can be further improved by using
a selection of multiple stable reference loci. This can also be done
using the GLMM model (possibly accounting for interreplicate variability). Our measure of stability takes both bias and variance in
account. Because stable reference loci are expected to have the
same copy number, the ratio of their concentrations should be close
to one, or, in terms of model (34) or (35), the parameter estimates
ˆ 1kl should be close to zero. Hence, a ratio of one, or a parameˇ
ter estimate of zero corresponds to no bias. By making all pairwise
comparisons between a reference locus and all other reference loci,
and calculating the sum of the squared deviations from zero, an
estimate of the total squared bias of the reference locus is obtained:
optimal reference loci will have a low bias while loci with large bias
indicate that they are not in agreement with the other candidate
reference loci. Variance is taken into account by using the estimate
of the variance of the bias parameter estimate: loci that have a more

variable concentration across replicates or samples (as propagated
in the variance of the estimate) are less ideal reference loci.
The stability measure is thus penalising aberrant reference loci
in two ways: loci that have a concentration deviating from other
reference loci will be penalised as well as those with higher variance. Optimal reference loci are both in accordance with other
reference loci and show little variation when replicated. Reference
loci having similar bias will be ranked from lower to higher variance, and likewise loci with similar variance will be ranked from
lower to higher bias. Fig. 5 indicates that for example for patient
sample 5, the genes LNX2, LAMA3 and C18ORF62 are most stable
and can be used as reference loci.
When sequentially adding reference loci from stable to less stable (best case scenario), the uncertainty of the target estimate ﬁrst
decreases, but increases again when more unstable reference loci
are added (U shape of the curve, Fig. 5). Excluding unstable reference loci may thus lead to a more accurate estimate while inclusion
of multiple stable reference loci typically also enhances the precision of the estimate. When all reference loci are stable, more
reference loci means less uncertainty and exclusion of reference
loci is disadvantageous (Supplementary Material 2 Figs. 7 and 8).
Sequentially adding reference loci in reverse order (worst case
scenario), i.e. using one or more less stable reference loci, may result
in severe bias (Fig. 5): only when the more stable reference loci are
added to the pool of reference loci the bias gets close to that of
the best case scenario. Even though the bias may converge to that
of the best case scenario when using just a few reference loci, the
uncertainty of the estimate may still remain higher than what is
observed under a best case scenario.
Relative expression stability determination necessitates a different approach as the ratio of reference gene concentrations is
generally not close to one, but should be stable across all samples
[7]. Taking a bias parameter (deviation from a ratio of one) into
account would wrongly discount good reference genes for relative
expression estimation. We suggest a modiﬁed stability criterion for
this scenario, taking only variability of the ratio into account. Thus,
genes that have a variable concentration ratio across samples and
within samples (technical replication) will be considered less ideal
than genes displaying a stable ratio across and within samples. This
approach is similar to the widely adopted stability measurement
described by Vandesompele et al. [7].
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Fig. 5. Assessing reference stability. Top: Mean absolute deviation from integer copy numbers as a function of the number of reference loci in sample 5. The reference loci
are added in the order of decreasing stability (best case) or increasing stability (worst case). Using an increasing number of reference loci results in a copy number estimate
that is less biased. Especially when only a few reference loci are used and those reference loci are not stable, the copy number bias may be considerably larger. Middle:
Uncertainty on target estimates, expressed as the width of a 95% conﬁdence interval, as a function of the number of reference loci in sample 5. The reference loci are added
in the order of decreasing stability (best case) or increasing stability (worst case). In terms of obtaining precise estimates, it is better to select the most stable reference genes
and omitting the less stable reference genes. In this case, the optimal number of reference genes is 3 as the uncertainty is lowest in this case. Bottom: Stability of candidate
reference loci in sample 5. Loci on LNX2, LAMA3 and C18ORF62 are more stable than the others.

3.3. Case study results
Copy numbers were measured in duplex (Fig. 1E) for 10 patient
samples and analyzed using the appropriate models given in
Section 2. A summary of all obtained aberrations is listed in Table 1.
A full list of estimated copy numbers and conﬁdence intervals is
available as Supplementary Table 2. For 9 out of the 10 samples at
least one target locus (located on the aberrant chromosome) was

conﬁrmed, i.e. the 95% conﬁdence interval contained the integer
copy number. In those 9 samples there was also a clear aberration of the non-conﬁrmed loci located on the chromosome with
the aberration, supporting the evidence for the conﬁrmed loci (Supplementary Table 2). Sample 10 displayed an unusual proﬁle which
we were unable to identify (no loci with (close to) normal diploid
copy number). The obtained aberrations using ddPCR correspond to
those obtained using state-of-the-art methods (karyotyping, FISH,
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Fig. 6. Copy numbers in sample 15. Copy numbers in sample 15 after normalization using the RPP30 locus (accounting for interreplicate variability). There appears to be a
general underestimation of the copy number, which may be due to aberrant quantiﬁcation of the RPP30 locus: the measured concentration of the RPP30 locus is too high, so
that the copy number of the target loci, expected to have two or three copies, are all underestimated.

Table 1
Overview of detected chromosomal abnormalities with conﬁrmed loci.
Sample

Detected aberration

Conﬁrmed loci

5
6
9
10
13
15
16
18
19
20

Chromosome 21 trisomy
Chromosome 21 trisomy
Isochromosome Xq
–
Chromosome 18 trisomy
Chromosome 18 trisomy
Chromosome 21 trisomy
Chromosome 18 trisomy
Isochromosome Xq
Chromosome 21 trisomy

CLIC6
DSCR3, SYNJ1
AMELX
–
C18ORF62, LAMA3
C18ORF62, LAMA3, SMCHD1
CLIC6, DSCR3, SYNJ1
LAMA3
AMELX, IL13RA1, ATP11C
CLIC6, DSCR3, SYNJ1

arrayCGH), except for the previously mentioned sample 10 that
was not identiﬁable using our ddPCR results (identiﬁed to be a 45,X
(Turner syndrome) sample using karyotyping, FISH and arrayCGH).
We discuss the case of patient sample 15, but the approach for
the other samples is similar (Supplementary Material 3). The setup
of the study was to assess chromosomal aberrations, i.e. deviations
from diploid copy numbers on 13 target loci. The reference locus
was located on the RPP30 gene. The results of normalization using
the RPP30 locus (accounting for interreplicate variability) is displayed in Fig. 6. It is clear we are dealing with a sample belonging
to a female (absence of positive droplets of the Y chromosome loci,
Supplementary Table 3), but all copy numbers seem to be deviating: there is a general underestimation of the copy number, which

may be due to aberrant quantiﬁcation of the RPP30 locus. It can furthermore be seen that the C18ORF623, LAMA3 and SMCHD1 loci (all
located on chromosome 18) seem to have a higher copy number
than loci located on the other chromosomes and that a chromosome 18 trisomy is likely. We thus use the loci on chromosomes
X, 13, 21 and the locus on RPP30 as candidate reference loci and
determine the stability of these loci as described in the Materials
and Methods section. The stability plot (Fig. 7) indicates that the
loci on LNX2, IL13RA1, SYNJ1, CLIC6, ITGBL1 and DSCR3 are of similar
stability, with rising instability thereafter for the loci on ATP11C,
RPP30 and AMELX. The latter three are thus excluded as reference
loci and the copy numbers of the three chromosome 18 loci recalculated using the six stable reference loci. The results are shown in
the bottom panel of Fig. 8: the 95% conﬁdence intervals of the multiple reference locus normalized results encompass the expected
integer copy number for all three loci for a trisomy 18 case.
3.4. Comments and further research
Even though the assumption of only one chromosomal aberration turned out to be correct in our case study, it is generally to
be recommended to determine candidate reference loci upfront.
For CNV determination it will not always be clear whether e.g.
a non-integer increase in a chromsome 18 loci combined with
a non-integer decrease in chromosome 13 loci corresponds to a
chromosome 18 trisomy or a chromosome 13 monosomy. This can
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Fig. 7. Stability of candidate reference loci in sample 15. Loci on LNX2, IL13RA1, SYNJ1, CLIC6, ITGBL1 and DSCR3 are of similar stability, with rising instability thereafter for
the loci on ATP11C, RPP30 and AMELX.

furter be complicated due to contamination of sample material by
e.g. maternal DNA. When using the framework for detection of noninteger copy numbers, the reference locus selection approach used
in our case study can no longer be used and determination of stable
reference loci upfront is needed.
We evaluated our method by calculating a deviation measure
from integer copy numbers, assuming that the samples did not display any mosaicism. This approach is only valid under the ideal
circumstances of no mosaicism, no contamination, . . .and deviation from this ideal scenario may have affected our case study
ﬁndings.
We demonstrated that accounting for variation between replicates and/or reference genes is necessary to obtain correct standard
errors of estimated absolute or relative quantities. These are
sources of variations that can be accounted for in a majority of
experiments as the use of replicate experiments and multiple reference genes are nowadays widely implemented. We want to stress
that there are additional sources of variation, and depending on
the experimental setup these can also be taken into account by

e.g. adding additional random effects for plate effects, run effects,
cartridge effects, . . .

3.5. Software implementation
R code and a tutorial demonstrating the implementation of
these models is available as Supplementary Material 1: we give
examples of how to analyze different types of data using the
models proposed in this manuscript. By providing easy to use
functions, the practitioner is able to determine reference gene
stability and perform absolute quantiﬁcation (with or without
replicates) and CNV/relative expression analysis (with one or more
reference genes and with or without replicates) with a few lines
of code. Additionally, a Shiny web application is available at
http://antonov.ugent.be:3838/dPCR/ that does not require any type
of programming, but relies on a spreadsheet-like data input and
point and click interface. A manual for using this web interface is
also available (Supplementary Material 5).
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